FDA Approved: WIDAPLIK — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

WIDAPLIK received FDA approval as an original NDA for a fixed-dose combination of telmisartan, amlodipine, and indapamide for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• WIDAPLIK (telmisartan, amlodipine and indapamide)

Snippet

ORIG AP for WIDAPLIK (TELMISARTAN, AMLODIPINE AND INDAPAMIDE)